tiprankstipranks
Trending News
More News >
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market

Compare ImmunoCellular Therapeutics (IMUC) vs. Competitors

Compare
186 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ImmunoCellular Therapeutics
$0.18
$20.39M
39.53%
Xenetic Biosciences
$2.21
$5.06M
-1.11
-44.68%
Adial Pharmaceuticals
$0.22
$6.20M
-0.25
-77.75%
1 Buy
0 Hold
0 Sell
Moderate Buy
VYNE Therapeutics
$0.57
$18.86M
-0.72
-79.46%
1 Buy
1 Hold
0 Sell
Moderate Buy
IN8bio
$2.21
$10.24M
-0.35
-74.48%
2 Buy
0 Hold
0 Sell
Moderate Buy
Bolt Biotherapeutics
$6.45
$12.38M
-0.31
-32.88%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMUC
ImmunoCellular Therapeutics
0.18
0.02
13.21%
XBIO
Xenetic Biosciences
2.28
-1.97
-46.38%
ADIL
Adial Pharmaceuticals
0.23
-0.81
-78.17%
VYNE
VYNE Therapeutics
0.57
-2.01
-78.02%
INAB
IN8bio
2.32
-6.58
-73.93%
BOLT
Bolt Biotherapeutics
6.98
-3.44
-33.01%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts